Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 03-03-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to adopt passive investment strategy. The fund will invest in stocks comprising in the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
MSCI India Domestic & World Healthcare 45 Index N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Taurus Ethical Fund - Regular Plan - Growth Option Mar 20, 2009 31.04 12.49 14.31 2.55 50.58
Principal Nifty 100 Equal Weight Fund-Growth Jul 27, 1999 39.75 8.87 12.68 0.96 21.24

Fund Holdings as on 31-January-2021

  • Dr. Reddy's Laboratories Ltd.

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • JOHNSON & JOHNSON

  • Aurobindo Pharma Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Lupin Ltd.

  • Biocon Ltd.

  • ABBOTT LABORATORIES

  • THERMO FISHER SCIENTIFIC INC

  • NOVARTIS AG

  • PFIZER INC

  • MERCK & CO.INC

  • Torrent Pharmaceuticals Ltd.

  • IPCA Laboratories Ltd.

  • ABBVIE INC

  • Laurus Labs Ltd.

  • Clearing Corporation of India Ltd.

  • DANAHER CORP

  • MEDTRONIC PLC

  • AMGEN INC

  • BRISTOL-MYERS SQUIBB COMPANY

  • Natco Pharma Ltd.

  • Abbott India Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • FORTIS HEALTHCARE LIMITED

  • Sanofi India Ltd.

  • Syngene International Ltd.

  • Dr. Lal Path Labs Ltd.

  • Jubilant Life Sciences Ltd.

  • Pfizer Ltd.

  • Alembic Pharmaceuticals Ltd.

  • GILEAD SCIENCES INC

  • Metropolis Healthcare Ltd.

  • BECTON DICKINSON AND CO

  • STRYKER CORP

  • Procter & Gamble Health Ltd.

  • Ajanta Pharma Ltd.

  • ILLUMINA INC

  • VERTEX PHARMACEUTICALS INC

  • BIOGEN INC

  • AGILENT TECHNOLOGIES INC

  • IQVIA HOLDINGS INC

  • METTLER-TOLEDO INTERNATIONAL

  • Astrazeneca Pharma India Ltd.

  • Reverse Repo

  • Net Receivables/(Payables)

View More
  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

View More

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Scheme Analysis

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a Index Funds - Other fund and belongs to Edelweiss Mutual Fund. It was launched on 26-Oct-2020 and currently has an AUM of ₹129.26 crore. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is benchmarked against MSCI India Domestic & World Healthcare 45 Index as primary index.

The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund ended up ₹0.01(0.09%)yesterday to ₹10.7951.

Among its top 3 holdings the fund has exposure to Dr. Reddy's Laboratories Ltd., and

The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is managed by Hardik Verma and Amit Vora.

Fund House Contact

Edelweiss House Off. C.S.T Road, Kalina, Mumbai - 400 098

(022) 40933400
(022) 40933401